Naiyer Rizvi, MD, Price Family Professor of Medicine and Director of Thoracic Oncology, Co-Director of Cancer Immunotherapy, Columbia Irving Medical Center discusses biomarker roles in identifying lung cancer patients who are most likely to benefit from therapies.
Biomarkers in Lung Cancer Treatment
